为解决 CAR-T 细胞疗法成本高、生产受限等问题,研究人员开展了利用睡美人(SB)转座子工程化供体来源的抗 CD19.CD28.OX40.CD3ζ T 细胞(CAR CIK-CD19)治疗异基因造血干细胞移植(alloHSCT)后复发的 B 细胞前体急性淋巴细胞白血病(BCP-ALL)的研究。结果显示该疗法 ...
1Children’s Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas. 10Howard Hughes Medical Institute, UT Southwestern Medical Center, ...